Suppr超能文献

血管内注射阿替普酶与支架取栓中的初次通过效应相关,但与 ADAPT 血栓切除术无关:SKIP 研究的事后分析。

Intravenous Alteplase is Associated with First Pass Effect in Stent-retriever but not ADAPT Thrombectomy : Post Hoc Analysis of the SKIP Study.

机构信息

Department of Neurosurgery, National Hospital Organization Disaster Medical Center, Tokyo, Japan.

Department of Neurology, Nippon Medical School Hospital, Tokyo, Japan.

出版信息

Clin Neuroradiol. 2022 Mar;32(1):153-162. doi: 10.1007/s00062-021-01085-3. Epub 2021 Sep 8.

Abstract

PURPOSE

To investigate the effect of alteplase, either combined with stent-retriever thrombectomy or a direct aspiration first pass technique (ADAPT), in patients with large-vessel occlusion stroke.

METHODS

This was a retrospective post hoc analysis of data from The Direct Mechanical Thrombectomy in Acute LVO Stroke (SKIP) study. Patients were divided into two groups according to the first-line thrombectomy technique: stent-retriever and ADAPT. Each group was further divided into two subgroups, namely MT and MT + alteplase. The procedural outcomes, such as first pass effect (FPE) ratio and number of passes, were evaluated. The clinical outcomes included mRS score at 3 months.

RESULTS

A total of 180 patients were included (116 in the stent-retriever group and 64 in the ADAPT group). No interaction was detected between the first-line technique and alteplase administration. In the stent-retriever group, after adjusting for factors associated with FPE, the adjusted odds ratio (95% confidence interval) of FPE of the MT + alteplase subgroup versus the MT subgroup was 3.57 (1.5-8.48) and in the ADAPT group it was 1.35 (0.37-4.91). With alteplase, the number of passes decreased with adjusted odds ratios of 0.59 (0.37-0.93) in the stent-retriever group but not in the ADAPT group. In both first-line technique groups, clinical outcomes did not differ between subgroups.

CONCLUSION

In the SKIP study, alteplase administration was associated with increased FPE when combined with stent-retriever thrombectomy, but not with ADAPT. We found no differences in the clinical outcomes.

摘要

目的

研究阿替普酶联合支架取栓术或直接抽吸首过技术(ADAPT)对大血管闭塞性脑卒中患者的影响。

方法

这是一项对急性大血管闭塞性卒中直接机械取栓(SKIP)研究数据的回顾性事后分析。根据一线取栓技术将患者分为支架取栓组和 ADAPT 组。每组进一步分为支架取栓术和支架取栓术联合阿替普酶两组。评估了手术结果,如首过效应(FPE)率和通过次数。临床结局包括 3 个月时 mRS 评分。

结果

共纳入 180 例患者(支架取栓组 116 例,ADAPT 组 64 例)。未发现一线技术与阿替普酶给药之间存在交互作用。在支架取栓组中,在调整与 FPE 相关的因素后,支架取栓术联合阿替普酶组与单纯支架取栓组的 FPE 调整比值比(95%置信区间)为 3.57(1.5-8.48),而在 ADAPT 组为 1.35(0.37-4.91)。阿替普酶组中,通过次数减少,调整比值比为 0.59(0.37-0.93),而在 ADAPT 组中无此变化。在两组一线技术组中,亚组间临床结局无差异。

结论

在 SKIP 研究中,阿替普酶联合支架取栓术可增加 FPE,但与 ADAPT 联合使用则不然。我们发现临床结局无差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验